NCT07335211

Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

A Multicenter, Randomized, Single-blind, Active Controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 206 (estimated)
• Sponsor: Huons Co., Ltd. · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

A multicenter, randomized, single-blind, active controlled, phase III clinical trial to evaluate the efficacy and safety of HUC3-637 in patients with primary open angle glaucoma or ocular hypertension

Conditions

• Primary Open Angle Glaucoma (POAG)
• Ocular Hypertension

Interventions

Type	Name	Description
DRUG	HUC3-637	Ophthalmic solution instilled directly into the eye (topical ocular administration)
DRUG	HUC3-637-R	Ophthalmic solution instilled directly into the eye (topical ocular administration)

Timeline

• Start date: 2026-01-01
• Primary completion: 2027-11-01
• Completion: 2027-12-01
• First posted: 2026-01-13
• Last updated: 2026-01-13

Locations

1 site across 1 country: South Korea